Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference f72e767e55
Drug names280First applicant · distinct drug namesAcceptance records438First applicant · distinct acceptance numbersUnder-review numbers60First applicant · current under-review listCo-applicant records18Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/12 06:41.
Drug filings
438 acceptance records as first applicant, grouped into 280 source drug names. Source data as of 2026/11/12 06:41.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
丙泊酚乳状注射液 · No verified English name 1 records · Latest accepted 2026/11/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602760 | Generic | 2026/11/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
注射用头孢呋辛钠/氯化钠注射液 · No verified English name 1 records · Latest accepted 2026/11/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602720 | Generic | 2026/11/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Nicorandil Tablets 2 records · Latest accepted 2026/10/20
Supplement · 1Generic · 1
碳酸氢钠血滤置换液(钾4mmol/L无钙) · No verified English name 1 records · Latest accepted 2026/10/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602473 | Generic | 2026/10/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
金莲花口服液 · No verified English name 1 records · Latest accepted 2026/09/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604864 | Supplement | 2026/09/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Tirofiban Hydrochloride And Sodium Chloride Injection 2 records · Latest accepted 2026/09/01
Supplement · 2
Perindopril arginine and amlodipine besylate tablets 2 records · Latest accepted 2026/08/21
Supplement · 2
Allopurinol Tablets 2 records · Latest accepted 2026/08/04
Supplement · 1Generic · 1
对乙酰氨基酚甘露醇注射液 · No verified English name 3 records · Latest accepted 2026/07/30
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601463 | Supplement | 2026/07/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2601462 | Supplement | 2026/07/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2300503 | Supplement | 2023/03/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Norepinephrine Bitartrate Injection 2 records · Latest accepted 2026/07/28
Supplement · 1Generic · 1
参乌健脑胶囊 · No verified English name 1 records · Latest accepted 2026/07/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2603666 | Supplement | 2026/07/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
替硝唑氯化钠注射液 · No verified English name 1 records · Latest accepted 2026/07/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601399 | Supplement | 2026/07/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Bromfenac Sodium Eye Drops 1 records · Latest accepted 2026/06/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601517 | Generic | 2026/06/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
碳酸氢钠血滤置换液(钾2mmol/L无钙) · No verified English name 1 records · Latest accepted 2026/06/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601500 | Generic | 2026/06/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
碳酸氢钠血滤置换液(无钾、无钙、0.6mmol/L镁) · No verified English name 1 records · Latest accepted 2026/06/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601304 | Generic | 2026/06/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
碳酸氢钠血滤置换液(钾4mmol/L) · No verified English name 1 records · Latest accepted 2026/06/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601295 | Generic | 2026/06/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
注射用头孢唑肟钠 · No verified English name 2 records · Latest accepted 2026/05/15
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600956 | Supplement | 2026/05/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2600955 | Supplement | 2026/05/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Olopatadine Hydrochloride Eye Drops 1 records · Latest accepted 2026/05/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601145 | Generic | 2026/05/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Teicoplanin for Injection 1 records · Latest accepted 2026/04/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600877 | Generic | 2026/04/16 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
左奥硝唑氯化钠注射液 · No verified English name 1 records · Latest accepted 2026/04/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600865 | Generic | 2026/04/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
低钙腹膜透析液(乳酸盐-G2.55%) · No verified English name 1 records · Latest accepted 2026/04/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600812 | Generic | 2026/04/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ciprofloxacin Lactate and Sodium Chloride Injection 3 records · Latest accepted 2026/03/20
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600543 | Supplement | 2026/03/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2402150 | Supplement | 2024/12/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2200599 | Supplement | 2022/04/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Vancomycin Hydrochloride for Injection 1 records · Latest accepted 2026/03/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600636 | Generic | 2026/03/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
洛度沙胺氨丁三醇滴眼液 · No verified English name 1 records · Latest accepted 2026/03/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600598 | Generic | 2026/03/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Jiangxi Ke Lun Pharma Co., Ltd. romanized | CDE ↗ |
低钙腹膜透析液(乳酸盐-G1.35%) · No verified English name 1 records · Latest accepted 2026/03/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600590 | Generic | 2026/03/01 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
低钙腹膜透析液(乳酸盐-G1.76%) · No verified English name 1 records · Latest accepted 2026/02/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600507 | Generic | 2026/02/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Sodium Bicarbonate Injection 8 records · Latest accepted 2026/02/03
Supplement · 6Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600216 | Supplement | 2026/02/03 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501788 | Supplement | 2025/09/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2302249 | Generic | 2023/08/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301989 | Generic | 2023/07/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2350502 | Supplement | 2023/06/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201048 | Supplement | 2022/06/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101073 | Supplement | 2021/04/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2100253 | Supplement | 2021/02/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ambroxol Hydrochloride Oral Solution 1 records · Latest accepted 2026/01/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600279 | Generic | 2026/01/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
磷/碳酸氢钠血滤置换液 · No verified English name 1 records · Latest accepted 2026/01/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600274 | Generic | 2026/01/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2026/01/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600226 | Generic | 2026/01/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
碳酸氢钠血滤置换液 · No verified English name 1 records · Latest accepted 2026/01/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600055 | Generic | 2026/01/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性低钙腹膜透析液(碳酸氢盐-G1.5%) · No verified English name 3 records · Latest accepted 2025/12/26
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504437 | Generic | 2025/12/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2503750 | Generic | 2025/10/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501560 | Generic | 2025/04/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
多种微量元素注射液(III) · No verified English name 1 records · Latest accepted 2025/12/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504358 | Generic | 2025/12/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性腹膜透析液(碳酸氢盐-G1.5%) · No verified English name 3 records · Latest accepted 2025/12/22
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504343 | Generic | 2025/12/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2503666 | Generic | 2025/10/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501645 | Generic | 2025/05/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
多种微量元素注射液(I) · No verified English name 1 records · Latest accepted 2025/12/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504271 | Generic | 2025/12/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性低钙腹膜透析液(碳酸氢盐-G2.5%) · No verified English name 3 records · Latest accepted 2025/12/02
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504138 | Generic | 2025/12/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2503727 | Generic | 2025/10/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501794 | Generic | 2025/05/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
吸入用布地奈德混悬液 · No verified English name 1 records · Latest accepted 2025/11/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504093 | Generic | 2025/11/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性腹膜透析液(碳酸氢盐-G2.5%) · No verified English name 3 records · Latest accepted 2025/11/24
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504045 | Generic | 2025/11/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2503862 | Generic | 2025/11/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501765 | Generic | 2025/05/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Mycophenolate Mofetil for Injection 1 records · Latest accepted 2025/11/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504038 | Generic | 2025/11/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
阿奇霉素分散片 · No verified English name 1 records · Latest accepted 2025/11/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550370 | Supplement | 2025/11/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Selegiline Hydrochloride Tablets 1 records · Latest accepted 2025/11/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503885 | Generic | 2025/11/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Potassium Phosphates Injection 2 records · Latest accepted 2025/11/04
Supplement · 1Generic · 1
苹果酸奈诺沙星氯化钠注射液 · No verified English name 1 records · Latest accepted 2025/10/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503833 | Generic | 2025/10/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Labetalol Hydrochloride Tablets 1 records · Latest accepted 2025/10/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503757 | Generic | 2025/10/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Dapagliflozin Tablets 3 records · Latest accepted 2025/10/12
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501987 | Supplement | 2025/10/12 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2300929 | Generic | 2023/03/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2300928 | Generic | 2023/03/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
注射用磷酸左奥硝唑酯二钠 · No verified English name 1 records · Latest accepted 2025/10/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503627 | Generic | 2025/10/11 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸地尔硫?片 · No verified English name 1 records · Latest accepted 2025/09/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550333 | Supplement | 2025/09/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Potassium Aspartate And Magnesium Aspartate Injection 1 records · Latest accepted 2025/09/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503549 | Generic | 2025/09/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性低钙腹膜透析液(乳酸盐-G1.5%) · No verified English name 1 records · Latest accepted 2025/09/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503317 | Generic | 2025/09/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性腹膜透析液(乳酸盐-G1.5%) · No verified English name 1 records · Latest accepted 2025/09/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503298 | Generic | 2025/09/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Vonoprazan Fumarate Tablets 4 records · Latest accepted 2025/08/30
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501737 | Supplement | 2025/08/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501736 | Supplement | 2025/08/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301960 | Generic | 2023/07/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301959 | Generic | 2023/07/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Dobutamine Hydrochloride Injection 1 records · Latest accepted 2025/08/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503006 | Generic | 2025/08/16 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Alogliptin Benzoate Tablets 1 records · Latest accepted 2025/08/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502905 | Generic | 2025/08/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性低钙腹膜透析液(乳酸盐-G2.5%) · No verified English name 1 records · Latest accepted 2025/08/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502805 | Generic | 2025/08/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性腹膜透析液(乳酸盐-G2.5%) · No verified English name 1 records · Latest accepted 2025/08/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502806 | Generic | 2025/08/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Cefditoren Pivoxil Granules 1 records · Latest accepted 2025/08/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502780 | Generic | 2025/08/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ropivacaine hydrochloride injection 2 records · Latest accepted 2025/07/30
Supplement · 2
Isoprenaline Hydrochloride Injection 2 records · Latest accepted 2025/07/23
Supplement · 1Generic · 1
Magnesium Sulfate Injection 5 records · Latest accepted 2025/07/22
Supplement · 2Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501457 | Supplement | 2025/07/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501010 | Supplement | 2025/05/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201367 | Generic | 2022/08/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201366 | Generic | 2022/08/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201365 | Generic | 2022/08/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Bromhexine Hydrochloride Oral Solution 1 records · Latest accepted 2025/07/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502586 | Generic | 2025/07/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Phenylephrine Hydrochloride Injection 2 records · Latest accepted 2025/07/16
Supplement · 1Generic · 1
葡萄糖注射液 · No verified English name 15 records · Latest accepted 2025/07/08
Supplement · 15
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501337 | Supplement | 2025/07/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501214 | Supplement | 2025/06/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400470 | Supplement | 2024/04/03 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Shandong Ke Lun Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2300596 | Supplement | 2023/03/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2300595 | Supplement | 2023/03/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2300594 | Supplement | 2023/03/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2300593 | Supplement | 2023/03/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201163 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201162 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201161 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201160 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201143 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201142 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201141 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201140 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Finerenone Tablets 1 records · Latest accepted 2025/07/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502407 | Generic | 2025/07/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Scopolamine Butylbromide Injection 1 records · Latest accepted 2025/07/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502393 | Generic | 2025/07/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
氨吡啶缓释片 · No verified English name 1 records · Latest accepted 2025/06/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502225 | Generic | 2025/06/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
氨基酸(15)腹膜透析液 · No verified English name 1 records · Latest accepted 2025/06/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502220 | Generic | 2025/06/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸纳美芬注射液 · No verified English name 1 records · Latest accepted 2025/06/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502174 | Generic | 2025/06/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸精氨酸注射液 · No verified English name 1 records · Latest accepted 2025/06/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502154 | Generic | 2025/06/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性低钙腹膜透析液(碳酸氢盐-G4.25%) · No verified English name 1 records · Latest accepted 2025/06/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502102 | Generic | 2025/06/12 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Acetylcysteine Injection 2 records · Latest accepted 2025/06/12
Generic · 2
Sacubitril Valsartan Sodium Tablets 1 records · Latest accepted 2025/06/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502050 | Generic | 2025/06/11 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Oseltamivir Phosphate Capsules 3 records · Latest accepted 2025/06/07
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502015 | Generic | 2025/06/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2502014 | Generic | 2025/06/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2404188 | Generic | 2024/12/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
中性腹膜透析液(碳酸氢盐-G4.25%) · No verified English name 1 records · Latest accepted 2025/05/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501913 | Generic | 2025/05/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Tropicamide Phenylephrine Eye Drops 1 records · Latest accepted 2025/05/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501683 | Generic | 2025/05/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
生理氯化钠溶液 · No verified English name 2 records · Latest accepted 2025/05/07
Supplement · 2
Propylthiouracil Tablets 1 records · Latest accepted 2025/04/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501572 | Generic | 2025/04/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Multiple Electrolytes Injection（Ⅱ） 2 records · Latest accepted 2025/04/24
Supplement · 2
Riluzole Tablets 1 records · Latest accepted 2025/04/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501511 | Generic | 2025/04/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Rasagiline Mesylate Tablets 2 records · Latest accepted 2025/04/17
Supplement · 1Generic · 1
Potassium Aspartate Injection 2 records · Latest accepted 2025/04/15
Generic · 2
Sodium Hyaluronate Eye Drops 2 records · Latest accepted 2025/03/26
Generic · 2
Gadobutrol Injection 1 records · Latest accepted 2025/03/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501091 | Generic | 2025/03/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Nimodipine Oral Solution 1 records · Latest accepted 2025/03/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501074 | Generic | 2025/03/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Zhejiang Guo Jing Pharma Co., Ltd. romanized | CDE ↗ |
甲氧氯普胺片 · No verified English name 2 records · Latest accepted 2025/03/14
Generic · 2
Letermovir Injection 1 records · Latest accepted 2025/03/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500985 | Generic | 2025/03/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Benidipine Hydrochloride Tablets 2 records · Latest accepted 2025/03/08
Generic · 2
Calcium Gluconate in Sodium Chloride Injection 3 records · Latest accepted 2025/02/22
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500820 | Generic | 2025/02/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2401493 | Generic | 2024/05/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2303292 | Generic | 2023/11/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Acetylcysteine Solution For Inhalation 1 records · Latest accepted 2025/02/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500810 | Generic | 2025/02/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Polyvinyl Alcohol Eye Drops 1 records · Latest accepted 2025/02/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500771 | Generic | 2025/02/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
枸橼酸钠血滤置换液 · No verified English name 1 records · Latest accepted 2025/02/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500761 | Generic | 2025/02/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Nimodipine Tablets 1 records · Latest accepted 2025/02/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500573 | Generic | 2025/02/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Potassium Chloride Injection 3 records · Latest accepted 2025/01/23
Generic · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500440 | Generic | 2025/01/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2350237 | Supplement | 2023/03/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2350236 | Supplement | 2023/03/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
维生素B12注射液 · No verified English name 2 records · Latest accepted 2025/01/23
Supplement · 2
Metformin Hydrochloride Tablets 2 records · Latest accepted 2025/01/14
Generic · 2
Methocarbamol Tablets 1 records · Latest accepted 2025/01/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500273 | Generic | 2025/01/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Dextran And Hypromellose Eye Drops 1 records · Latest accepted 2025/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500218 | Generic | 2025/01/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Indocyaninegreen for Injection 1 records · Latest accepted 2025/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500221 | Generic | 2025/01/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
脂肪乳氨基酸(17)葡萄糖(19%)注射液 · No verified English name 2 records · Latest accepted 2025/01/10
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500227 | Generic | 2025/01/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Sichuan Kelun Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2500226 | Generic | 2025/01/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Sichuan Kelun Pharmaceutical Co., Ltd. | CDE ↗ |
Perindopril Arginine Tablets 2 records · Latest accepted 2025/01/09
Generic · 2
Choline Fenofibrate Sustained-release Capsules 1 records · Latest accepted 2025/01/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500124 | Generic | 2025/01/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
山梨醇甘露醇冲洗剂 · No verified English name 1 records · Latest accepted 2025/01/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500017 | Supplement | 2025/01/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Lincomycin Injection 1 records · Latest accepted 2025/01/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550001 | Supplement | 2025/01/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Cimetidine Injection 1 records · Latest accepted 2024/12/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404606 | Generic | 2024/12/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
SYN045片 · No verified English name 9 records · Latest accepted 2024/12/27
Supplement · 3New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2400306 | Supplement | 2024/12/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2400305 | Supplement | 2024/12/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2400304 | Supplement | 2024/12/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301235 | New drug | 2023/11/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301234 | New drug | 2023/11/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301233 | New drug | 2023/11/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301232 | New drug | 2023/11/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301231 | New drug | 2023/11/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301230 | New drug | 2023/11/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
氯化钠注射液 · No verified English name 12 records · Latest accepted 2024/12/26
Supplement · 12
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402221 | Supplement | 2024/12/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401640 | Supplement | 2024/10/12 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400211 | Supplement | 2024/02/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2301672 | Supplement | 2023/07/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Shandong Ke Lun Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201711 | Supplement | 2022/09/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201165 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201164 | Supplement | 2022/07/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201019 | Supplement | 2022/06/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2200975 | Supplement | 2022/06/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101933 | Supplement | 2021/09/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101932 | Supplement | 2021/09/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101655 | Supplement | 2021/08/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
艾考糊精腹膜透析液 · No verified English name 1 records · Latest accepted 2024/12/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400271 | Generic | 2024/12/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Safinamide Methansulfonate Tablets 2 records · Latest accepted 2024/12/21
Generic · 2
Procaterol Hydrochloride Solution for Inhalation 2 records · Latest accepted 2024/12/17
Generic · 2
头孢泊肟酯干混悬剂 · No verified English name 1 records · Latest accepted 2024/12/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404352 | Generic | 2024/12/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Emedastine Difumarate Eye Drops 1 records · Latest accepted 2024/12/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404335 | Generic | 2024/12/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
帕拉米韦氯化钠注射液 · No verified English name 2 records · Latest accepted 2024/12/06
Generic · 2
Sodium Cromoglicate Eye Drops 1 records · Latest accepted 2024/12/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404207 | Generic | 2024/12/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Bumetanide Injection 2 records · Latest accepted 2024/12/02
Generic · 2
Tranexamic Acid Tablets 2 records · Latest accepted 2024/11/25
Generic · 2
Propranolol Hydrochloride Injection 2 records · Latest accepted 2024/11/14
Generic · 2
Drotaverine Hydrochloride Tablets 1 records · Latest accepted 2024/11/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403792 | Generic | 2024/11/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
肌苷注射液 · No verified English name 1 records · Latest accepted 2024/11/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401828 | Supplement | 2024/11/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
注射用盐酸地尔硫? · No verified English name 1 records · Latest accepted 2024/11/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403777 | Generic | 2024/11/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Sodium Lactate Ringer's Irrigation Solution 1 records · Latest accepted 2024/10/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403652 | Generic | 2024/10/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸多沙普仑注射液 · No verified English name 1 records · Latest accepted 2024/10/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403501 | Generic | 2024/10/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
复方电解质醋酸钠葡萄糖注射液 · No verified English name 2 records · Latest accepted 2024/10/15
Generic · 2
维生素B6注射液 · No verified English name 4 records · Latest accepted 2024/10/11
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450508 | Supplement | 2024/10/11 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450193 | Supplement | 2024/03/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450192 | Supplement | 2024/03/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450191 | Supplement | 2024/03/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Doxazosin Mesylate Extended Release Tablets 1 records · Latest accepted 2024/09/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403188 | Generic | 2024/09/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Metoclopramide Hydrochloride Injection 1 records · Latest accepted 2024/09/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403189 | Generic | 2024/09/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Perindopril Arginine and Amlodipine Besylate Tablets(III) 1 records · Latest accepted 2024/09/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402967 | Generic | 2024/09/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Vitamin K1 Injection 1 records · Latest accepted 2024/09/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402966 | Generic | 2024/09/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Fat-Soluble Vitamin Injection（Ⅰ） 1 records · Latest accepted 2024/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402823 | Generic | 2024/08/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Fat-Soluble Vitamin Injection（Ⅱ） 1 records · Latest accepted 2024/08/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402718 | Generic | 2024/08/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
甘油磷酸钠注射液 · No verified English name 1 records · Latest accepted 2024/08/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402687 | Generic | 2024/08/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Moxifloxacin Hydrochloride And Sodium Chloride Injection 1 records · Latest accepted 2024/08/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401247 | Supplement | 2024/08/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Levofolinate Calcium for Injection 1 records · Latest accepted 2024/08/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402504 | Generic | 2024/08/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Tolterodine Tartrate Extended Release Capsules 1 records · Latest accepted 2024/07/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402399 | Generic | 2024/07/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Levofloxacin Eye Drops 1 records · Latest accepted 2024/07/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402135 | Generic | 2024/07/12 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Jiangxi Ke Lun Pharma Co., Ltd. romanized | CDE ↗ |
Propafenone Hydrochloride Injection 1 records · Latest accepted 2024/07/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402115 | Generic | 2024/07/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
苯磺酸左氨氯地平片 · No verified English name 2 records · Latest accepted 2024/07/10
Generic · 2
低钙腹膜透析液(乳酸盐-G4.25%) · No verified English name 1 records · Latest accepted 2024/07/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450365 | Supplement | 2024/07/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Sodium Bicarbonate Ringer’s Injection 2 records · Latest accepted 2024/06/28
Supplement · 1Generic · 1
复方匹可硫酸钠颗粒 · No verified English name 1 records · Latest accepted 2024/06/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401788 | Generic | 2024/06/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Aminophylline Tablets 1 records · Latest accepted 2024/06/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401784 | Generic | 2024/06/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Mannitol-S Injection 2 records · Latest accepted 2024/06/08
Generic · 2
Fluvoxamine Maleate Tablets 3 records · Latest accepted 2024/04/28
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401286 | Generic | 2024/04/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301358 | Generic | 2023/05/19 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301357 | Generic | 2023/05/19 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Indobufen Tablets 1 records · Latest accepted 2024/04/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401248 | Generic | 2024/04/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
氯化钾氯化钠注射液 · No verified English name 2 records · Latest accepted 2024/04/24
Generic · 2
Citicoline Sodium Injection 6 records · Latest accepted 2024/04/23
Supplement · 4Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400526 | Supplement | 2024/04/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400363 | Supplement | 2024/03/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400052 | Supplement | 2024/01/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400051 | Supplement | 2024/01/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201248 | Generic | 2022/08/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2200323 | Generic | 2022/02/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Labetalol Hydrochloride Injection 1 records · Latest accepted 2024/04/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401131 | Generic | 2024/04/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ademetionine 1,4 - Butanedisulfonate For Injection 1 records · Latest accepted 2024/04/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401105 | Generic | 2024/04/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Arginine and Ibuprofen Granules 2 records · Latest accepted 2024/04/10
Generic · 2
氯化钙注射液 · No verified English name 1 records · Latest accepted 2024/03/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400950 | Generic | 2024/03/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Diprophylline Injection 1 records · Latest accepted 2024/03/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400931 | Generic | 2024/03/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
复方醋酸钠林格注射液 · No verified English name 1 records · Latest accepted 2024/03/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400900 | Generic | 2024/03/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸尼卡地平氯化钠注射液 · No verified English name 1 records · Latest accepted 2024/03/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400895 | Generic | 2024/03/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Morinidazole and Sodium Chloride Injection 1 records · Latest accepted 2024/03/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400893 | Generic | 2024/03/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Calcium Gluconate Injection 1 records · Latest accepted 2024/03/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400869 | Generic | 2024/03/19 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Formoterol Fumarate Inhalation Solution 1 records · Latest accepted 2024/03/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400837 | Generic | 2024/03/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸左沙丁胺醇雾化吸入溶液 · No verified English name 1 records · Latest accepted 2024/03/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400827 | Generic | 2024/03/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Bilastine Tablets 1 records · Latest accepted 2024/03/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400804 | Generic | 2024/03/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Paracetamol Tablets 2 records · Latest accepted 2024/03/06
Supplement · 2
Azithromycin For Injection 4 records · Latest accepted 2024/03/06
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400344 | Supplement | 2024/03/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2250308 | Supplement | 2022/06/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hebei Ai Er Hai Tai Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2101387 | Supplement | 2021/06/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hebei Ai Er Hai Tai Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2101386 | Supplement | 2021/06/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hebei Ai Er Hai Tai Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Furosemide Injection 1 records · Latest accepted 2024/02/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450147 | Supplement | 2024/02/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Furosemide Tablets 1 records · Latest accepted 2024/02/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400646 | Generic | 2024/02/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Argatroban Injection 2 records · Latest accepted 2024/02/21
Supplement · 1Generic · 1
Drotaverine Hydrochloride Injection 1 records · Latest accepted 2024/02/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400630 | Generic | 2024/02/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
水溶性黄体酮注射液 · No verified English name 1 records · Latest accepted 2024/02/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400541 | Generic | 2024/02/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Henan Ke Lun Pharma Co., Ltd. romanized | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2024/02/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400538 | Generic | 2024/02/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
复方电解质注射液(V) · No verified English name 1 records · Latest accepted 2024/02/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400510 | Generic | 2024/02/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Thioctic Acid Injection 2 records · Latest accepted 2024/02/06
Supplement · 1Generic · 1
Dronedarone Hydrochloride Tablets 1 records · Latest accepted 2024/02/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400464 | Generic | 2024/02/03 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Multiple Electrolytes and Sodium Acetate Injection 1 records · Latest accepted 2024/01/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400319 | Generic | 2024/01/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Urapidil Sustained-release Capsules 1 records · Latest accepted 2024/01/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400304 | Generic | 2024/01/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
腹膜透析液(乳酸盐-G1.5%) · No verified English name 2 records · Latest accepted 2024/01/20
Supplement · 2
Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2024/01/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400179 | Generic | 2024/01/12 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Tranexamic Acid and Sodium Chloride Injection 1 records · Latest accepted 2024/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400076 | Generic | 2024/01/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Acipimox Capsules 1 records · Latest accepted 2024/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400073 | Generic | 2024/01/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Timolol Maleate Eye Drops 2 records · Latest accepted 2024/01/06
Generic · 2
Gabexate Mesilate For Injection 1 records · Latest accepted 2023/12/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303631 | Generic | 2023/12/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Nicardipine Hydrochloride Injection 1 records · Latest accepted 2023/12/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303526 | Generic | 2023/12/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Voriconazole for Oral Suspension 1 records · Latest accepted 2023/12/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303395 | Generic | 2023/12/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Levocarnitine Oral Solution 1 records · Latest accepted 2023/12/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303380 | Generic | 2023/12/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
富马酸酮替芬滴眼液 · No verified English name 1 records · Latest accepted 2023/12/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303334 | Generic | 2023/12/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
小儿复方氨基酸注射液(20AA) · No verified English name 1 records · Latest accepted 2023/11/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302930 | Generic | 2023/11/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Potassium Chloride Granules 1 records · Latest accepted 2023/10/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302895 | Generic | 2023/10/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Glycerol Fructose And Sodium Chloride Injection 1 records · Latest accepted 2023/10/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350781 | Supplement | 2023/10/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
对乙酰氨基酚颗粒 · No verified English name 1 records · Latest accepted 2023/10/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302836 | Generic | 2023/10/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Vortioxetine Hydrobromide Tablets 3 records · Latest accepted 2023/10/13
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302754 | Generic | 2023/10/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201269 | Generic | 2022/08/11 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201268 | Generic | 2022/08/11 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
利巴韦林注射液 · No verified English name 1 records · Latest accepted 2023/09/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302200 | Supplement | 2023/09/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
醋酸钠林格葡萄糖注射液 · No verified English name 1 records · Latest accepted 2023/09/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302536 | Generic | 2023/09/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Nefopam Hydrochloride Injection 1 records · Latest accepted 2023/09/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350704 | Supplement | 2023/09/16 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Trelagliptin Succinate Tablets 1 records · Latest accepted 2023/09/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2300114 | Generic | 2023/09/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Lactated Ringer's Injection 1 records · Latest accepted 2023/08/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301949 | Supplement | 2023/08/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Deferasirox Dispersible Tablets 1 records · Latest accepted 2023/08/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302285 | Generic | 2023/08/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Felodipine Sustained Release Tablets 2 records · Latest accepted 2023/08/19
Supplement · 1Generic · 1
Tofacitinib Citrate Extended Release tablets 1 records · Latest accepted 2023/08/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302139 | Generic | 2023/08/16 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
NP-01片 · No verified English name 3 records · Latest accepted 2023/08/15
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300159 | Supplement | 2023/08/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2300158 | Supplement | 2023/08/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2300157 | Supplement | 2023/08/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Alprostadil Injection 2 records · Latest accepted 2023/07/31
Generic · 2
腹膜透析液(乳酸盐-G4.25%) · No verified English name 1 records · Latest accepted 2023/07/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350602 | Supplement | 2023/07/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Gliclazide Tablets 1 records · Latest accepted 2023/06/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350498 | Supplement | 2023/06/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸肾上腺素注射液 · No verified English name 1 records · Latest accepted 2023/05/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301442 | Generic | 2023/05/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Phloroglucinol Injection 1 records · Latest accepted 2023/05/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301413 | Generic | 2023/05/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Multiple Electrolytes Injection 1 records · Latest accepted 2023/05/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350446 | Supplement | 2023/05/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Cycloserine Capsules 1 records · Latest accepted 2023/05/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301331 | Generic | 2023/05/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Lornoxicam for Injection 1 records · Latest accepted 2023/04/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301147 | Generic | 2023/04/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Isosorbide Dinitrate Injection 1 records · Latest accepted 2023/04/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301123 | Generic | 2023/04/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
醋酸维持液(含葡萄糖) · No verified English name 2 records · Latest accepted 2023/04/20
Generic · 2
Levodopa and Benserazide Hydrochloride Tablets 1 records · Latest accepted 2023/04/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301077 | Generic | 2023/04/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
平衡盐溶液(供灌注用) · No verified English name 1 records · Latest accepted 2023/04/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300757 | Supplement | 2023/04/11 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Cefdinir Capsules 2 records · Latest accepted 2023/04/04
Supplement · 2
Multiple Electrolyte Additive For Injection 1 records · Latest accepted 2023/04/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300956 | Generic | 2023/04/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
葡萄糖氯化钠注射液 · No verified English name 5 records · Latest accepted 2023/03/30
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300641 | Supplement | 2023/03/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2300640 | Supplement | 2023/03/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201100 | Supplement | 2022/07/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201099 | Supplement | 2022/07/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2201098 | Supplement | 2022/07/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Chlorphenamine Maleate Injection 2 records · Latest accepted 2023/03/13
Supplement · 2
依托咪酯中/长链脂肪乳注射液 · No verified English name 1 records · Latest accepted 2023/03/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300750 | Generic | 2023/03/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
布南色林片 · No verified English name 2 records · Latest accepted 2023/03/02
Supplement · 1Generic · 1
Esmolol Hydrochloride and Sodium Chloride Injection 1 records · Latest accepted 2023/02/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300581 | Generic | 2023/02/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Cefalexin Capsules 2 records · Latest accepted 2023/02/15
Supplement · 2
Lacosamide Injection 2 records · Latest accepted 2023/02/15
Supplement · 1Generic · 1
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2023/02/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300518 | Generic | 2023/02/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Betahistine Mesilate Tablets 1 records · Latest accepted 2023/02/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300412 | Generic | 2023/02/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Carbidopa and Levodopa Sustained-release Tablets 1 records · Latest accepted 2023/01/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300266 | Generic | 2023/01/31 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
乳酸左氧氟沙星氯化钠注射液 · No verified English name 3 records · Latest accepted 2023/01/13
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300116 | Supplement | 2023/01/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101149 | Supplement | 2021/04/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101148 | Supplement | 2021/04/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Esmolol Hydrochloride Injection 1 records · Latest accepted 2023/01/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300060 | Generic | 2023/01/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
脂肪乳(10%)/氨基酸(15)/葡萄糖(20%)注射液 · No verified English name 2 records · Latest accepted 2023/01/04
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300011 | Generic | 2023/01/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Sichuan Kelun Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2300010 | Generic | 2023/01/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Sichuan Kelun Pharmaceutical Co., Ltd. | CDE ↗ |
Entacapone,Levodopa and Carbidopa Tablets（Ⅱ） 1 records · Latest accepted 2022/12/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202089 | Generic | 2022/12/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Compound Dextran 40 Injection 1 records · Latest accepted 2022/11/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201937 | Generic | 2022/11/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Entacapone Tablets 1 records · Latest accepted 2022/11/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201917 | Generic | 2022/11/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Metoprolol Tartrate Injection 1 records · Latest accepted 2022/11/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250688 | Supplement | 2022/11/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Doxofylline Granules 1 records · Latest accepted 2022/11/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201871 | Generic | 2022/11/01 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
利奈唑胺干混悬剂 · No verified English name 1 records · Latest accepted 2022/10/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201787 | Generic | 2022/10/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸氨溴索氯化钠注射液 · No verified English name 1 records · Latest accepted 2022/10/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201874 | Supplement | 2022/10/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ondansetron Hydrochloride Injection 2 records · Latest accepted 2022/10/09
Generic · 2
低钙腹膜透析液(乳酸盐-G2.5%) · No verified English name 1 records · Latest accepted 2022/09/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250614 | Supplement | 2022/09/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Lidocaine Hydrochloride Injection 3 records · Latest accepted 2022/09/06
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201460 | Generic | 2022/09/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201459 | Generic | 2022/09/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201458 | Generic | 2022/09/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Nicorandil for Injection 1 records · Latest accepted 2022/08/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201328 | Generic | 2022/08/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hebei Ai Er Hai Tai Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Nifedipine Extended-Release Tablets 1 records · Latest accepted 2022/08/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201304 | Generic | 2022/08/16 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
低钙腹膜透析液(乳酸盐-G1.5%) · No verified English name 1 records · Latest accepted 2022/08/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250493 | Supplement | 2022/08/12 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
头孢呋辛酯干混悬剂 · No verified English name 2 records · Latest accepted 2022/08/03
Generic · 2
Ozagrel Sodium Injection 2 records · Latest accepted 2022/08/03
Generic · 2
Propofol Medium And Long Chain Fat Emulsion Injection 2 records · Latest accepted 2022/08/01
Generic · 2
Salbutamol Sulfate injection 1 records · Latest accepted 2022/07/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201078 | Generic | 2022/07/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Aminophylline Injection 2 records · Latest accepted 2022/07/15
Generic · 2
Arbidol Hydrochloride Tablets 1 records · Latest accepted 2022/07/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201031 | Generic | 2022/07/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸罗哌卡因氯化钠注射液 · No verified English name 1 records · Latest accepted 2022/07/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201023 | Generic | 2022/07/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Tedizolid Phosphate Tablets 1 records · Latest accepted 2022/07/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200984 | Generic | 2022/07/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
腹膜透析液(乳酸盐-G2.5%) · No verified English name 1 records · Latest accepted 2022/06/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250342 | Supplement | 2022/06/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Epalrestat Tablets 1 records · Latest accepted 2022/05/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200777 | Generic | 2022/05/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ornidazole Tablets 1 records · Latest accepted 2022/05/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200719 | Generic | 2022/05/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Tinidazole Tablets 1 records · Latest accepted 2022/05/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200698 | Generic | 2022/05/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
司替戊醇干混悬剂 · No verified English name 2 records · Latest accepted 2022/04/21
Generic · 2
利奈唑胺氯化钠注射液 · No verified English name 1 records · Latest accepted 2022/04/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200543 | Generic | 2022/04/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ondansetron Hydrochloride Tablets 2 records · Latest accepted 2022/04/08
Generic · 2
Tirofiban Hydrochloride Injection 1 records · Latest accepted 2022/03/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200496 | Generic | 2022/03/29 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
硫酸特布他林雾化吸入用溶液 · No verified English name 1 records · Latest accepted 2022/03/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200422 | Supplement | 2022/03/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Metronidazole and Sodium Chloride Injection 4 records · Latest accepted 2022/03/07
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200407 | Supplement | 2022/03/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2200406 | Supplement | 2022/03/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101837 | Supplement | 2021/09/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101836 | Supplement | 2021/09/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Tedizolid Phosphate For Injection 1 records · Latest accepted 2022/02/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200320 | Generic | 2022/02/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hebei Ai Er Hai Tai Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Urapidil Hydrochloride Injection 2 records · Latest accepted 2022/01/12
Generic · 2
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2022/01/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200020 | Generic | 2022/01/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Doxofylline Injection 1 records · Latest accepted 2022/01/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200009 | Supplement | 2022/01/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Cinacalcet Hydrochloride Tablets 1 records · Latest accepted 2021/12/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102153 | Generic | 2021/12/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Pentoxifylline Modified Release Tablets 1 records · Latest accepted 2021/11/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102028 | Generic | 2021/11/19 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Rosuvastatin Calcium Tablets 3 records · Latest accepted 2021/11/17
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2102119 | Supplement | 2021/11/17 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101497 | Supplement | 2021/07/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101038 | Supplement | 2021/03/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Terbutaline Sulfate Injection 1 records · Latest accepted 2021/10/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101884 | Generic | 2021/10/19 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ornidazole Injection 2 records · Latest accepted 2021/10/11
Generic · 2
Lurasidone Hydrochloride Tablets 1 records · Latest accepted 2021/09/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101759 | Generic | 2021/09/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Pitavastatin Calcium Tablets 2 records · Latest accepted 2021/09/13
Generic · 2
Mecobalamin Injection 1 records · Latest accepted 2021/09/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150847 | Supplement | 2021/09/01 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
血液滤过置换基础液 · No verified English name 1 records · Latest accepted 2021/08/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101730 | Supplement | 2021/08/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
羟乙基淀粉130/0.4氯化钠注射液 · No verified English name 1 records · Latest accepted 2021/07/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150768 | Supplement | 2021/07/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Valsartan and Amlodipine Tablets（I） 1 records · Latest accepted 2021/07/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101486 | Generic | 2021/07/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Azithromycin Tablets 1 records · Latest accepted 2021/07/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101485 | Generic | 2021/07/27 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Azithromycin for Suspension 1 records · Latest accepted 2021/07/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101417 | Generic | 2021/07/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Dexmedetomidine Hydrochloride Injection 1 records · Latest accepted 2021/06/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101291 | Generic | 2021/06/11 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Ipratropium Bromide Inhalation Solution 2 records · Latest accepted 2021/06/10
Generic · 2
头孢克洛干混悬剂 · No verified English name 1 records · Latest accepted 2021/06/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150659 | Supplement | 2021/06/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Fluconazole Tablets 2 records · Latest accepted 2021/04/27
Supplement · 2
中/长链脂肪乳注射液(C8~24Ve) · No verified English name 1 records · Latest accepted 2021/04/26
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101164 | Supplement | 2021/04/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Heilongjiang Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Pentoxifylline Injection 1 records · Latest accepted 2021/04/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101051 | Generic | 2021/04/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Fluconazole and Sodium Chloride Injection 1 records · Latest accepted 2021/03/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100301 | Generic | 2021/03/31 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Dexmedetomidine Hydrochloride Injection 2 records · Latest accepted 2021/02/24
Generic · 2
Levofloxacin Injection 1 records · Latest accepted 2021/02/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100189 | Generic | 2021/02/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Moxifloxacin Hydrochloride Eye Drops 1 records · Latest accepted 2021/02/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100169 | Generic | 2021/02/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Shijiazhuang Gree Pharmaceutical Co., Ltd | CDE ↗ |
口服补液盐散(III) · No verified English name 1 records · Latest accepted 2019/10/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS1900744 | Generic | 2019/10/31 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸雷尼替丁胶囊 · No verified English name 1 records · Latest accepted 2019/08/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB1950591 | Supplement | 2019/08/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
27 events from 2026/08/15 to 2026/11/12. CDE data as of 2026/11/12 06:41; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Marketing application approved: 3 applicationsAccepted: 8 applicationsNo longer listed under review: 11 applicationsSupplement delivery: 3 applicationsNotification delivery: 2 applications
- 2026/11/10No longer listed under review
中性低钙腹膜透析液(碳酸氢盐-G2.5%) · No verified English name
CYHS2501794
Fact date: 2026/11/10 · Site observation date: 2026/11/10
Accepted: 2025/05/17
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/10Accepted
丙泊酚乳状注射液 · No verified English name
CYHS2602760
Fact date: 2026/11/10 · Site observation date: 2026/11/11
View source ↗ - 2026/11/06No longer listed under review
参乌健脑胶囊 · No verified English name
CYZB2603666
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2026/07/24
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/04); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 75
NMPA · Table row 75 ↗ View source ↗ - 2026/11/06No longer listed under review
Allopurinol Tablets
CYHB2601493
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2026/08/04
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/04); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 23
NMPA · Table row 23 ↗ View source ↗ - 2026/11/05No longer listed under review
盐酸精氨酸注射液 · No verified English name
CYHS2502154
Fact date: 2026/11/05 · Site observation date: 2026/11/05
Accepted: 2025/06/17
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/05No longer listed under review
中性低钙腹膜透析液(碳酸氢盐-G4.25%) · No verified English name
CYHS2502102
Fact date: 2026/11/05 · Site observation date: 2026/11/05
Accepted: 2025/06/12
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/05Accepted
注射用头孢呋辛钠/氯化钠注射液 · No verified English name
CYHS2602720
Fact date: 2026/11/05 · Site observation date: 2026/11/06
View source ↗ - 2026/11/04Supplement delivery
参乌健脑胶囊 · No verified English name
CYZB2603666
Fact date: 2026/11/04 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 75 ↗ - 2026/11/04Supplement delivery
Allopurinol Tablets
CYHB2601493
Fact date: 2026/11/04 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 23 ↗ - 2026/11/04No longer listed under review
中性腹膜透析液(碳酸氢盐-G4.25%) · No verified English name
CYHS2501913
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2025/05/29
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/04No longer listed under review
中性腹膜透析液(碳酸氢盐-G2.5%) · No verified English name
CYHS2501765
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2025/05/15
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/04No longer listed under review
阿奇霉素分散片 · No verified English name
CYHB2550370
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2025/11/22
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/03 (approval no.: —; approval date: 2026/11/02); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 4
NMPA · Table row 4 ↗ View source ↗ - 2026/11/03Marketing application approved
Sacubitril Valsartan Sodium Tablets
CYHS2502050 · 国药准字H20266451
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
View source · Table row 82 ↗ - 2026/11/03Marketing application approved
Tropicamide Phenylephrine Eye Drops
CYHS2501683 · 国药准字H20266468
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
View source · Table row 68 ↗ - 2026/11/03Marketing application approved
Tofacitinib Citrate Extended Release tablets
CYHS2302139 · 国药准字H20266433
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
View source · Table row 5 ↗ - 2026/11/02Supplement delivery
阿奇霉素分散片 · No verified English name
CYHB2550370
Fact date: 2026/11/02 · Publication date: 2026/11/03 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 4 ↗ - 2026/10/31No longer listed under review
中性低钙腹膜透析液(碳酸氢盐-G1.5%) · No verified English name
CYHS2501560
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2025/04/25
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/28Notification delivery
Riluzole Tablets
CYHS2501511
Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 11 ↗ - 2026/10/28No longer listed under review
中性腹膜透析液(碳酸氢盐-G1.5%) · No verified English name
CYHS2501645
Fact date: 2026/10/28 · Site observation date: 2026/10/28
Accepted: 2025/05/07
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/23No longer listed under review
替硝唑氯化钠注射液 · No verified English name
CYHB2601399
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/07/23
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 7
NMPA · Table row 7 ↗ View source ↗ - 2026/10/22Notification delivery
替硝唑氯化钠注射液 · No verified English name
CYHB2601399
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 7 ↗ - 2026/10/20Accepted
Nicorandil Tablets
CYHB2601913
Fact date: 2026/10/20 · Site observation date: 2026/10/22
View source ↗ - 2026/10/10Accepted
碳酸氢钠血滤置换液(钾4mmol/L无钙) · No verified English name
CYHS2602473
Fact date: 2026/10/10 · Site observation date: 2026/10/22
View source ↗ - 2026/09/21Accepted
金莲花口服液 · No verified English name
CYZB2604864
Fact date: 2026/09/21 · Site observation date: 2026/10/22
View source ↗ - 2026/09/01Accepted
Tirofiban Hydrochloride And Sodium Chloride Injection
CYHB2601669
Fact date: 2026/09/01 · Site observation date: 2026/10/22
View source ↗ - 2026/08/21Accepted
Perindopril arginine and amlodipine besylate tablets
CYHB2601579
Fact date: 2026/08/21 · Site observation date: 2026/10/22
View source ↗ - 2026/08/21Accepted
Perindopril arginine and amlodipine besylate tablets
CYHB2601578
Fact date: 2026/08/21 · Site observation date: 2026/10/22
View source ↗
Under review
60 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 丙泊酚乳状注射液 · No verified English name | CYHS2602760 | Generic | 2026/11/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用头孢呋辛钠/氯化钠注射液 · No verified English name | CYHS2602720 | Generic | 2026/11/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Nicorandil Tablets | CYHB2601913 | Supplement | 2026/10/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 碳酸氢钠血滤置换液(钾4mmol/L无钙) · No verified English name | CYHS2602473 | Generic | 2026/10/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 金莲花口服液 · No verified English name | CYZB2604864 | Supplement | 2026/09/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Tirofiban Hydrochloride And Sodium Chloride Injection | CYHB2601669 | Supplement | 2026/09/01 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Perindopril arginine and amlodipine besylate tablets | CYHB2601579 | Supplement | 2026/08/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Perindopril arginine and amlodipine besylate tablets | CYHB2601578 | Supplement | 2026/08/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 对乙酰氨基酚甘露醇注射液 · No verified English name | CYHB2601463 | Supplement | 2026/07/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 对乙酰氨基酚甘露醇注射液 · No verified English name | CYHB2601462 | Supplement | 2026/07/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Norepinephrine Bitartrate Injection | CYHB2601445 | Supplement | 2026/07/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Bromfenac Sodium Eye Drops | CYHS2601517 | Generic | 2026/06/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 碳酸氢钠血滤置换液(钾2mmol/L无钙) · No verified English name | CYHS2601500 | Generic | 2026/06/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 碳酸氢钠血滤置换液(无钾、无钙、0.6mmol/L镁) · No verified English name | CYHS2601304 | Generic | 2026/06/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 碳酸氢钠血滤置换液(钾4mmol/L) · No verified English name | CYHS2601295 | Generic | 2026/06/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Olopatadine Hydrochloride Eye Drops | CYHS2601145 | Generic | 2026/05/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Teicoplanin for Injection | CYHS2600877 | Generic | 2026/04/16 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 左奥硝唑氯化钠注射液 · No verified English name | CYHS2600865 | Generic | 2026/04/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 低钙腹膜透析液(乳酸盐-G2.55%) · No verified English name | CYHS2600812 | Generic | 2026/04/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Vancomycin Hydrochloride for Injection | CYHS2600636 | Generic | 2026/03/10 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 洛度沙胺氨丁三醇滴眼液 · No verified English name | CYHS2600598 | Generic | 2026/03/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Jiangxi Ke Lun Pharma Co., Ltd. romanized | CDE ↗ |
| 低钙腹膜透析液(乳酸盐-G1.35%) · No verified English name | CYHS2600590 | Generic | 2026/03/01 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 低钙腹膜透析液(乳酸盐-G1.76%) · No verified English name | CYHS2600507 | Generic | 2026/02/25 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Ambroxol Hydrochloride Oral Solution | CYHS2600279 | Generic | 2026/01/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 磷/碳酸氢钠血滤置换液 · No verified English name | CYHS2600274 | Generic | 2026/01/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Upadacitinib Sustained-release Tablets | CYHS2600226 | Generic | 2026/01/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 碳酸氢钠血滤置换液 · No verified English name | CYHS2600055 | Generic | 2026/01/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性低钙腹膜透析液(碳酸氢盐-G1.5%) · No verified English name | CYHS2504437 | Generic | 2025/12/26 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 多种微量元素注射液(III) · No verified English name | CYHS2504358 | Generic | 2025/12/23 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性腹膜透析液(碳酸氢盐-G1.5%) · No verified English name | CYHS2504343 | Generic | 2025/12/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 多种微量元素注射液(I) · No verified English name | CYHS2504271 | Generic | 2025/12/13 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性低钙腹膜透析液(碳酸氢盐-G2.5%) · No verified English name | CYHS2504138 | Generic | 2025/12/02 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 吸入用布地奈德混悬液 · No verified English name | CYHS2504093 | Generic | 2025/11/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性腹膜透析液(碳酸氢盐-G2.5%) · No verified English name | CYHS2504045 | Generic | 2025/11/24 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Mycophenolate Mofetil for Injection | CYHS2504038 | Generic | 2025/11/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Selegiline Hydrochloride Tablets | CYHS2503885 | Generic | 2025/11/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性腹膜透析液(碳酸氢盐-G2.5%) · No verified English name | CYHS2503862 | Generic | 2025/11/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 苹果酸奈诺沙星氯化钠注射液 · No verified English name | CYHS2503833 | Generic | 2025/10/30 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Labetalol Hydrochloride Tablets | CYHS2503757 | Generic | 2025/10/22 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性低钙腹膜透析液(碳酸氢盐-G1.5%) · No verified English name | CYHS2503750 | Generic | 2025/10/21 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性低钙腹膜透析液(碳酸氢盐-G2.5%) · No verified English name | CYHS2503727 | Generic | 2025/10/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性腹膜透析液(碳酸氢盐-G1.5%) · No verified English name | CYHS2503666 | Generic | 2025/10/14 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用磷酸左奥硝唑酯二钠 · No verified English name | CYHS2503627 | Generic | 2025/10/11 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Potassium Aspartate And Magnesium Aspartate Injection | CYHS2503549 | Generic | 2025/09/28 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性低钙腹膜透析液(乳酸盐-G1.5%) · No verified English name | CYHS2503317 | Generic | 2025/09/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性腹膜透析液(乳酸盐-G1.5%) · No verified English name | CYHS2503298 | Generic | 2025/09/05 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Dobutamine Hydrochloride Injection | CYHS2503006 | Generic | 2025/08/16 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Alogliptin Benzoate Tablets | CYHS2502905 | Generic | 2025/08/09 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性腹膜透析液(乳酸盐-G2.5%) · No verified English name | CYHS2502806 | Generic | 2025/08/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 中性低钙腹膜透析液(乳酸盐-G2.5%) · No verified English name | CYHS2502805 | Generic | 2025/08/04 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Bromhexine Hydrochloride Oral Solution | CYHS2502586 | Generic | 2025/07/18 | Shijiazhuang No.4 Pharmaceutical Co., Ltd.; Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Finerenone Tablets | CYHS2502407 | Generic | 2025/07/08 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Scopolamine Butylbromide Injection | CYHS2502393 | Generic | 2025/07/07 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 氨吡啶缓释片 · No verified English name | CYHS2502225 | Generic | 2025/06/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 氨基酸(15)腹膜透析液 · No verified English name | CYHS2502220 | Generic | 2025/06/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Acetylcysteine Injection | CYHS2502117 | Generic | 2025/06/12 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Potassium Aspartate Injection | CYHS2501430 | Generic | 2025/04/15 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Nimodipine Tablets | CYHS2500573 | Generic | 2025/02/06 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 口服补液盐散(III) · No verified English name | CYHS1900744 | Generic | 2019/10/31 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 盐酸雷尼替丁胶囊 · No verified English name | CYHB1950591 | Supplement | 2019/08/20 | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
243 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/12 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Letermovir Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265881 | 2026/09/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸地尔硫?片 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H10920025 | 2026/08/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Indocyaninegreen for Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265715 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ozagrel Sodium Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265660 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ozagrel Sodium Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265659 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 氯化钾注射液(II) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265451 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 甲氧氯普胺片 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265618 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cimetidine Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265390 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 枸橼酸钠血滤置换液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265263 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 脂肪乳氨基酸(17)葡萄糖(19%)注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20265337 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Benidipine Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265289 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 脂肪乳氨基酸(17)葡萄糖(19%)注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20265336 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Choline Fenofibrate Sustained-release Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265181 | 2026/07/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propylthiouracil Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265080 | 2026/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcium Gluconate in Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265096 | 2026/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Methocarbamol Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264995 | 2026/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Safinamide Methansulfonate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264809 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Safinamide Methansulfonate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264810 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 头孢泊肟酯干混悬剂 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264658 | 2026/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perindopril Arginine Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264362 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 帕拉米韦氯化钠注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264443 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 帕拉米韦氯化钠注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264442 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bumetanide Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264440 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264236 | 2026/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Drotaverine Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264257 | 2026/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264247 | 2026/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 甲氧氯普胺片 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264265 | 2026/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264246 | 2026/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 维生素B12注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20269103 | 2026/04/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metformin Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264165 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metformin Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264164 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fat-Soluble Vitamin Injection（Ⅰ） | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264209 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Doxazosin Mesylate Extended Release Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264172 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propranolol Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264062 | 2026/04/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 注射用盐酸地尔硫? · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264090 | 2026/04/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方电解质醋酸钠葡萄糖注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263900 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metoclopramide Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263897 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方电解质醋酸钠葡萄糖注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263899 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tranexamic Acid Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263816 | 2026/03/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bumetanide Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263723 | 2026/03/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofolinate Calcium for Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263515 | 2026/03/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸多沙普仑注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263474 | 2026/02/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propafenone Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263257 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Phosphates Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20269017 | 2026/01/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perindopril Arginine and Amlodipine Besylate Tablets(III) | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20256451 | 2025/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 甘油磷酸钠注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20256351 | 2025/12/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方醋酸钠林格注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20256203 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acetylcysteine Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20256176 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方匹可硫酸钠颗粒 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20256107 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tolterodine Tartrate Extended Release Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20256041 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ademetionine 1,4 - Butanedisulfonate For Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20256006 | 2025/11/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Indobufen Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255947 | 2025/11/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lincomycin Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13020016 | 2025/10/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 维生素B6注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20258233 | 2025/10/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 苯磺酸左氨氯地平片 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255720 | 2025/10/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Magnesium Sulfate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20258222 | 2025/10/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 苯磺酸左氨氯地平片 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255721 | 2025/10/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Isoprenaline Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20258201 | 2025/09/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Morinidazole and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255446 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcium Gluconate in Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255396 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 黄体酮注射液(II) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Henan Ke Lun Pharma Co., Ltd. romanized | 国药准字H20255284 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 氯化钙注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255325 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perindopril Arginine Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255324 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Labetalol Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255291 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方电解质注射液(V) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255283 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Multiple Electrolytes and Sodium Acetate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255299 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Allopurinol Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255209 | 2025/08/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Urapidil Sustained-release Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255197 | 2025/08/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Drotaverine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255218 | 2025/08/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸尼卡地平氯化钠注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255201 | 2025/08/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Benidipine Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20255176 | 2025/08/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcium Gluconate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254837 | 2025/07/15 | Not stated by source | CDE ↗ |
| 氯化钾氯化钠注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254795 | 2025/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 氯化钾氯化钠注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254796 | 2025/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 对乙酰氨基酚颗粒 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254709 | 2025/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Furosemide Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254676 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diprophylline Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254634 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tranexamic Acid and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254511 | 2025/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcium Gluconate in Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254348 | 2025/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Chloride Granules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254319 | 2025/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 低钙腹膜透析液(乳酸盐-G4.25%) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20193084 | 2025/05/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dronedarone Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254075 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gabexate Mesilate For Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254110 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Arginine and Ibuprofen Granules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253922 | 2025/04/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Arginine and Ibuprofen Granules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253904 | 2025/04/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253948 | 2025/04/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Ringer’s Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20258059 | 2025/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Citicoline Sodium Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20258050 | 2025/04/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Citicoline Sodium Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20258049 | 2025/04/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicardipine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253729 | 2025/03/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253723 | 2025/03/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Arbidol Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253696 | 2025/03/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Voriconazole for Oral Suspension | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253658 | 2025/03/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸肾上腺素注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253598 | 2025/03/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253531 | 2025/03/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluvoxamine Maleate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253471 | 2025/02/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acipimox Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253441 | 2025/02/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253161 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Phosphates Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253133 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253008 | 2025/01/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20253007 | 2025/01/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paracetamol Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13022470 | 2024/12/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Paracetamol Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20247328 | 2024/12/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 醋酸钠林格葡萄糖注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20249846 | 2024/12/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Furosemide Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13020021 | 2024/12/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Deferasirox Dispersible Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20249708 | 2024/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方醋酸钠葡萄糖注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20249561 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方醋酸钠葡萄糖注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20249560 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glycerol Fructose And Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20044027 | 2024/11/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Phenylephrine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20249214 | 2024/10/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cycloserine Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20249079 | 2024/10/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lornoxicam for Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20249068 | 2024/10/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nefopam Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13020028 | 2024/09/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nicorandil Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244753 | 2024/08/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Phloroglucinol Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244676 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Norepinephrine Bitartrate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244708 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Multiple Electrolyte Additive For Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244640 | 2024/08/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levodopa and Benserazide Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244644 | 2024/08/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Entacapone,Levodopa and Carbidopa Tablets（Ⅱ） | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244519 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluvoxamine Maleate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244601 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 脂肪乳(10%)/氨基酸(15)/葡萄糖(20%)注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20244521 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 脂肪乳(10%)/氨基酸(15)/葡萄糖(20%)注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20244520 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Betahistine Mesilate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244384 | 2024/07/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 依托咪酯中/长链脂肪乳注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244346 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244369 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Isosorbide Dinitrate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244311 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Isoprenaline Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244337 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244370 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carbidopa and Levodopa Sustained-release Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244261 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esmolol Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244116 | 2024/06/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esmolol Hydrochloride and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244006 | 2024/06/11 | Not stated by source | CDE ↗ |
| Bisoprolol Fumarate and Amlodipine Besylate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243824 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 腹膜透析液(乳酸盐-G4.25%) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20193080 | 2024/05/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Entacapone Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243840 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 对乙酰氨基酚甘露醇注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20247113 | 2024/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20247111 | 2024/05/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ondansetron Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243751 | 2024/05/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ondansetron Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243750 | 2024/05/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rasagiline Mesylate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243701 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Multiple Electrolytes Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20133245 | 2024/05/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 利奈唑胺干混悬剂 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243512 | 2024/04/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 头孢呋辛酯干混悬剂 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243388 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 头孢呋辛酯干混悬剂 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243389 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lidocaine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243412 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lidocaine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243411 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lidocaine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243413 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefalexin Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20247058 | 2024/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefalexin Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13022518 | 2024/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gliclazide Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13021831 | 2024/02/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nicorandil for Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Hebei Ai Er Hai Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20243218 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Ringer’s Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243187 | 2024/02/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propofol Medium And Long Chain Fat Emulsion Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243138 | 2024/02/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propofol Medium And Long Chain Fat Emulsion Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243137 | 2024/02/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20247013 | 2024/01/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Magnesium Sulfate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243044 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243027 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Magnesium Sulfate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243037 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Magnesium Sulfate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243043 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Chlorphenamine Maleate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20247003 | 2024/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Chlorphenamine Maleate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13020020 | 2024/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropivacaine hydrochloride injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20237066 | — | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸罗哌卡因氯化钠注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234720 | 2023/12/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 硝苯地平缓释片(II) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234699 | 2023/12/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tedizolid Phosphate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234566 | 2023/11/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tirofiban Hydrochloride And Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20183523 | 2023/11/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Potassium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20183142 | 2023/11/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Aminophylline Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234392 | 2023/10/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aminophylline Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234391 | 2023/10/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metoprolol Tartrate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20093974 | 2023/10/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ondansetron Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234368 | 2023/10/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Epalrestat Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234370 | 2023/10/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ondansetron Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234369 | 2023/10/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Salbutamol Sulfate injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234323 | 2023/10/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 利奈唑胺氯化钠注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234267 | 2023/10/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tinidazole Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234207 | 2023/09/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ornidazole Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20234208 | 2023/09/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 低钙腹膜透析液(乳酸盐-G2.5%) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20193082 | 2023/08/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 低钙腹膜透析液(乳酸盐-G1.5%) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20193083 | 2023/08/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 司替戊醇干混悬剂 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233970 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 司替戊醇干混悬剂 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233969 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233925 | 2023/07/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pitavastatin Calcium Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233861 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸替罗非班注射用浓溶液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233820 | 2023/06/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Citicoline Sodium Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233684 | 2023/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Urapidil Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233626 | 2023/05/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Urapidil Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233627 | 2023/05/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tedizolid Phosphate For Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Hebei Ai Er Hai Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20233604 | 2023/05/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cinacalcet Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233535 | 2023/05/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Acetate Ringer's Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20173310 | 2023/05/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Multiple Electrolytes Injection（Ⅱ） | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233462 | 2023/04/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Multiple Electrolytes Injection（Ⅱ） | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233463 | 2023/04/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 腹膜透析液(乳酸盐-G2.5%) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20193085 | 2023/04/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Argatroban Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233354 | 2023/03/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pentoxifylline Modified Release Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233310 | 2023/03/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin For Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Hebei Ai Er Hai Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20067807 | 2023/03/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lactated Ringer's Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20044961 | 2023/03/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lurasidone Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233178 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ornidazole Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233107 | 2023/01/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ornidazole Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233108 | 2023/01/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thioctic Acid Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233115 | 2023/01/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Terbutaline Sulfate Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233083 | 2023/01/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lacosamide Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223941 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Felodipine Sustained Release Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223964 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ciprofloxacin Lactate and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20227163 | 2022/12/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223821 | 2022/11/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pentoxifylline Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223704 | 2022/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valsartan and Amlodipine Tablets（I） | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223692 | 2022/09/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mecobalamin Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20066715 | 2022/09/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin for Suspension | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223641 | 2022/08/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 腹膜透析液(乳酸盐-G1.5%) · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20193081 | 2022/06/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 对乙酰氨基酚甘露醇注射液 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223397 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofloxacin Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223392 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 布南色林片 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223407 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rosuvastatin Calcium Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20227079 | 2022/06/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 头孢克洛干混悬剂 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20084562 | 2022/03/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metronidazole Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13022514 | 2022/03/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223140 | 2022/03/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223051 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Moxifloxacin Hydrochloride Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20223006 | 2022/01/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluconazole and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20213964 | 2021/12/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lacosamide Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20213763 | 2021/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lacosamide Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20213764 | 2021/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20213699 | 2021/09/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Linezolid and Glucose Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20213558 | 2021/06/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bromhexine Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20213214 | 2021/03/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metronidazole and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13022486 | 2021/02/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metronidazole and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13022487 | 2021/02/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fluconazole and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H10960198 | 2021/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ciprofloxacin Lactate and Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H13022479 | 2021/01/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ambroxol Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20183533 | 2020/12/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ambroxol Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20183532 | 2020/12/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ambroxol Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20183531 | 2020/12/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20183411 | 2020/11/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rosuvastatin Calcium Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | 2020/08/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Prucalopride Succinate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203310 | 2020/07/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Prucalopride Succinate Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203309 | 2020/07/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefdinir Capsules | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203289 | 2020/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluconazole Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H10970298 | 2019/04/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fluconazole Tablets | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H10970299 | 2019/04/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Propranolol Hydrochloride Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264063 | 2026/04/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fat-Soluble Vitamin Injection（Ⅱ） | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20263580 | 2026/03/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rosuvastatin Calcium and Ezetimibe Tablets (I) | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254910 | 2025/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadobutrol Injection | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20265740 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
1 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/12 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| NP-01 · No verified English name | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Y20190021524 | I | 2020/01/10 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
18 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 平衡盐溶液(供灌注用) · No verified English name | CYHS2602683 | Generic | 2026/11/03 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 生理氯化钠溶液 · No verified English name | CYHS2602085 | Generic | 2026/08/21 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 生理氯化钠溶液 · No verified English name | CYHS2601979 | Generic | 2026/08/12 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 头孢呋辛酯干混悬剂 · No verified English name | CYHB2601351 | Supplement | 2026/07/15 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 头孢呋辛酯干混悬剂 · No verified English name | CYHB2601350 | Supplement | 2026/07/15 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 生理氯化钠溶液 · No verified English name | CYHS2601054 | Generic | 2026/05/08 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefalexin Capsules | CYHB2600547 | Supplement | 2026/03/20 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefalexin Capsules | CYHB2600546 | Supplement | 2026/03/20 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 左奥硝唑氯化钠注射液 · No verified English name | CYHB2501308 | Supplement | 2025/07/04 | Beijing Shi Jin Yao Yuan Drug Research Institute romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 头孢呋辛酯干混悬剂 · No verified English name | CYHB2500212 | Supplement | 2025/01/25 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 头孢呋辛酯干混悬剂 · No verified English name | CYHB2500211 | Supplement | 2025/01/25 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 头孢羟氨苄胶囊 · No verified English name | CYHB2500095 | Supplement | 2025/01/14 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 头孢呋辛酯颗粒 · No verified English name | CYHB2500093 | Supplement | 2025/01/14 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefalexin Capsules | CYHB2500092 | Supplement | 2025/01/14 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefalexin Capsules | CYHB2500091 | Supplement | 2025/01/14 | Hebei Guang Xiang Pharmaceuticals Technology Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 左奥硝唑氯化钠注射液 · No verified English name | CYHB2400310 | Supplement | 2024/02/28 | Beijing Shi Jin Yao Yuan Drug Research Institute romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| 左奥硝唑氯化钠注射液 · No verified English name | CYHB2400309 | Supplement | 2024/02/28 | Beijing Shi Jin Yao Yuan Drug Research Institute romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
| Calcium Gluconate Injection | CYHB2350780 | Supplement | 2023/10/21 | Xi Nan Pharma Co., Ltd. romanized; Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/12 06:41
- Chemical-drug catalogue
- Last successful update: 2026/11/12 06:38
- Full API register
- Last successful update: 2026/11/12 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.